Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome | Zendy

Pascal Pigny | Zendy; S. Jonard | Zendy; Y. Robert | Zendy; Didier Dewailly | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome

Author(s) -

Pascal Pigny,

S. Jonard,

Y. Robert,

Didier Dewailly

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-2076

Subject(s) - antral follicle , polycystic ovary , anti müllerian hormone , anovulation , medicine , ovarian reserve , receiver operating characteristic , hyperandrogenism , gynecology , endocrinology , ovary , hormone , biology , infertility , pregnancy , insulin resistance , insulin , genetics

Despite its frequency, the polycystic ovary syndrome (PCOS) is still a difficult diagnosis in endocrinology, gynecology, and reproductive medicine. To help solve this issue, the Rotterdam consensus conference proposed to include the ultrasonographic follicle count as a new diagnostic criterion, in addition to hyperandrogenism and oligo-anovulation. Unfortunately, its assessment does not offer sufficient reliability worldwide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research